A middling Parent Pillar and a subpar Process Pillar help limit Alger Health Sciences C to a Morningstar Quantitative Rating of Neutral. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
- NAV / 1-Day Return 13.28 / 0.97 %
- Total Assets 168.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.760%
- Distribution Fee Level Low
- Share Class Type Level Load
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 241%
Morningstar’s Analysis AHSCX
Will AHSCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.